Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05272826
Title Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients (BOREALIS)
Acronym BOREALIS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Canadian Myeloma Research Group
Indications
Therapies
Age Groups: senior
Covered Countries CAN

Facility Status City State Zip Country Details
London Health Sciences Centre RECRUITING London Ontario N6A 5W9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field